Posted on 3/19/20
Pfizer Postpones Investor Event Due To Covid-19
Pfizer (NYSE:PFE) has postponed its March 31 Investor Day due to the threat of the coronavirus outbreak, adding that the timetable for rescheduling has not been . . .
Posted on 3/19/20
Johnson & Johnson's Coronavirus Vaccine Won't Be in Clinical Trials Until November
The little guys are winning the race to develop the first vaccine against the SARS-CoV-2 coronavirus that causes COVID-19.Moderna (NASDAQ:MRNA) started a phase 1 clinical trial . . .
Posted on 3/18/20
Hebrew University to Collaborate with Cytovia Therapeutics
NEW YORK and JERUSALEM, March 18, 2020 (GLOBE NEWSWIRE) -- Yissum, the technology transfer company of The Hebrew University of Jerusalem and Cytovia Therapeutics, Inc, a . . .
Posted on 3/18/20
Armata Pharmaceuticals Announces up to $5 Million Therapeutics Development Award from the Cystic Fibrosis Foundation
Armata Pharmaceuticals, Inc. (NYSE American: ARMP), a biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that the company has been awarded . . .
Posted on 3/18/20
Avalon Healthcare Solutions Ranks No. 2 on the inaugural 2020 Inc. 5000 Series
Inc. magazine today revealed that Avalon Healthcare Solutions is No. 2 on its inaugural Inc. 5000 Series: Florida list, the most prestigious ranking of the fastest-growing . . .
Posted on 3/18/20
Why Biogen, GW Pharmaceuticals, and Vertex Pharmaceuticals Stocks Jumped Today
What happenedShares of several biotechs jumped on Tuesday as the overall stock market rebounded from a major downturn yesterday on reports that a huge federal stimulus . . .
Posted on 3/18/20
Pfizer Plows Ahead With Coronavirus Vaccine Collaboration
On Tuesday, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) agreed to collaborate on the development of an experimental vaccine to prevent COVID-19 transmission. BioNTech's U.S. partner signed a . . .
Posted on 3/18/20
Merck Announces Positive Results for Its Investigational Chronic Cough Treatment
Merck's (NYSE:MRK) shareholders got some good news today. In addition to seeing the company's shares climb by about 5.3% -- as the broader stock market rebounded . . .
Posted on 3/18/20
Ralph Lauren Closes Its U.S. Stores Through April 1
Joining many of its retailing peers, Ralph Lauren (NYSE:RL) announced on Tuesday it will close its store base across North America beginning on March 18 and . . .
Posted on 3/18/20
Regeneron Could Start Testing a Coronavirus Cocktail Therapy by Early Summer
Regeneron Pharmaceuticals (NASDAQ:REGN) announced on Tuesday that its scientists have identified hundreds of viral-neutralizing antibodies that could potentially be used to protect against and treat the . . .
Posted on 3/18/20
Why Regeneron Pharmaceuticals Stock Is Bolting Higher Today
What happenedShares of Regeneron Pharmaceuticals (NASDAQ:REGN), a large-cap biotech company, are on fire today. The stock is up by a handsome 15.1% as of 11:52 a.m. . . .
Posted on 3/18/20
Most Aggressive States Against the Coronavirus – WalletHub Study
According to the World Health Organization, the primary way that coronavirus (COVID-19) spreads is through close interaction with other people. If people come into contact with . . .
Posted on 3/17/20
The Benchmark Company Closes Public Offering of $4.5M for Seelos Therapeutics
NEW YORK, March 17, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company today announced the closing on March 16th of an Underwritten Public Offering for Seelos Therapeutics, . . .
Posted on 3/17/20
Athenex Provides a Corporate Update
BUFFALO, N.Y., March 13, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies . . .
Posted on 3/17/20
Seelos Therapeutics Closes Public Offering of Common Stock
NEW YORK, March 16, 2020 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous . . .
Posted on 3/17/20
Tabula Rasa HealthCare Named Principal Distributor of the BioIntelliSense BioSticker for PACE
MOORESTOWN, N.J., March 17, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, enters . . .
Posted on 3/17/20
Regeneron Announces Important Advances in Novel COVID-19 Antibody Program
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the latest progress in its efforts to discover and develop a novel multi-antibody cocktail that can be administered as . . .
Posted on 3/17/20
DarioHealth Reports Fourth Quarter and Year End 2019 Results
DarioHealth Corp. (Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, today reported financial results for the fourth quarter and full year ended December 31, 2019 and . . .
Posted on 3/17/20
Pfizer and BioNTech to Co-Develop Potential COVID-19 Vaccine
EW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have agreed to a letter of intent . . .
Posted on 3/17/20
Sigilon Therapeutics Raises $80.3M Series B
Sigilon Therapeutics, Inc., a biotechnology company developing functional cures for patients with chronic diseases through its Shielded Living Therapeutics platform
Posted on 3/17/20
Better Buy: AbbVie vs. Johnson & Johnson
One company produces the top-selling pharmaceuticals in the world. The other is a household name that offers various consumer health products as well as pharmaceutical products. . . .
Posted on 3/17/20
Johnson & Johnson Says There's Insufficient Evidence Its HIV Drug Can Treat COVID-19
Johnson & Johnson (NYSE:JNJ) released a statement on Monday that said there wasn't sufficient evidence to suggest its HIV drug darunavir (DRV) can effectively treat COVID-19, . . .
Posted on 3/17/20
Why Pfizer Stock Is Tumbling Today
What happenedPharmaceutical behemoth Pfizer (NYSE:PFE) is having another bad day today. The drugmaker's shares plunged by a jaw-dropping 9.5% right out of the gate Monday morning. . . .
Posted on 3/17/20
Teladoc Health Reports 50% Spike in Daily Patient Visits
Teladoc Health (NYSE:TDOC) reported on Friday that the number of patient visits it has facilitated jumped 50% week over week. The virtual medical provider's services have . . .
Posted on 3/17/20
Teladoc Health: The Story Keeps Getting Better
SummaryTeladoc Health is garnering a lot of attention lately, but in my opinion, the company has had a strong bull case for years.I believe that this . . .
New York
